Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal ...

Sequel Med Tech and Diabeloop today announced a collaboration to integrate a new algorithm into the twiist automated insulin ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

Helping toddlers manage their Type 1 diabetes—typically a difficult task, due to their constant growth and development, not to mention fussiness—may now be a bit easier. The FDA has expanded its ...

Diabeloop & Sequel Med Tech ink partnership to integrate US FDA-cleared DBLG2 into the twiist AID system: Grenoble, France Friday, January 16, 2026, 16:00 Hrs [IST] Following the ...

A landmark study sheds new light on the heterogeneity of type 2 diabetes. The researchers employed an innovative algorithm to stratify people with type 2 diabetes using routine data and thus visualize ...

The U.S FDA approved Camaps FX for use in pregnant women with type 1 diabetes. This first, hybrid, closed-loop app was developed by Camdiab Ltd., a spinout from Cambridge University, allows ...

Insulet estimated that its total addressable market for automated insulin delivery will grow to a $9bn market value by 2028.

A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1 or Type 2 diabetes without ...